Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Chongqing Xishan Science and Technology Co's annualized return on invested capital (ROIC %) for the quarter that ended in Mar. 2026 was 1.83%.
Chongqing Xishan Science and Technology Co (SHSE:688576) ROIC % Explanation
ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.
There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.
Why is ROIC % important?
Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.
As of today, Chongqing Xishan Science and Technology Co's WACC % is 14.07%. Chongqing Xishan Science and Technology Co's ROIC % is 3.90% (calculated using TTM income statement data).
Chongqing Xishan Science and Technology Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.
Be Aware
Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Chongqing Xishan Science and Technology Co ROIC % Related Terms
Chongqing Xishan Science and Technology Co ROIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chongqing Xishan Science and Technology Co ROIC % Chart
Chongqing Xishan Science and Technology Co Annual Data
For the Medical Instruments & Supplies subindustry, Chongqing Xishan Science and Technology Co's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chongqing Xishan Science and Technology Co ROIC % vs Medical Devices & Instruments Industry
Note:
The Operating Income data used here is four times the quarterly (Mar. 2026) data.
The tax rate is limited to between 0% and 100%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chongqing Xishan Science and Technology Co (SHSE:688576) has a ROIC % of 1.83% as of Mar. 2026. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Chongqing Xishan Science and Technology Co and its competitors.
Is Chongqing Xishan Science and Technology Co's ROIC % too high?
Chongqing Xishan Science and Technology Co's current ROIC % is 1.83%. The Medical Devices & Instruments industry median ROIC % is 1.28. Chongqing Xishan Science and Technology Co's value of 1.83% is 43% above this industry median. Overall, Chongqing Xishan Science and Technology Co has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chongqing Xishan Science and Technology Co's ROIC % compare to ISRG and BDX?
Chongqing Xishan Science and Technology Co's ROIC % of 1.83% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROIC % is 1.28. Chongqing Xishan Science and Technology Co's value of 1.83% is 43% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROIC % for a Medical Devices & Instruments company?
The median ROIC % among Medical Devices & Instruments companies is 1.28, based on 846 companies in the industry. Companies in the top quartile (top 25%) have a ROIC % significantly above this median, while those in the bottom quartile fall well below. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chongqing Xishan Science and Technology Co's current ROIC % of 1.83% is 43% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROIC % mean?
A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Chongqing Xishan Science and Technology Co and its competitors. For the Medical Devices & Instruments industry, the median ROIC % is 1.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chongqing Xishan Science and Technology Co's current ROIC % is 1.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chongqing Xishan Science and Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Chongqing Xishan Science and Technology Co (SHSE:688576) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥53.66, compared to a current price of ¥36.33 — trading 32.3% below its estimated fair value. The current ROIC % is 1.83% and 43% above the Medical Devices & Instruments industry median of 1.28. Chongqing Xishan Science and Technology Co's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROIC % calculated?
ROIC % is calculated from a company's financial statements. For Chongqing Xishan Science and Technology Co (SHSE:688576), the current ROIC % is 1.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chongqing Xishan Science and Technology Co (SHSE:688576) Overvalued in 2026?
Based on GuruFocus' analysis, Chongqing Xishan Science and Technology Co stock appears to be undervalued.
The current stock price of ¥36.33 is trading 32.3% below its estimated GF Value™ of ¥53.66.
GuruFocus considers Chongqing Xishan Science and Technology Co to be Significantly Undervalued.
Key valuation signals for SHSE:688576:
ROIC %: 1.83%
GF Value™: ¥53.66 vs. price of ¥36.33 (32.3% below fair value)
Industry Position: 43% above the Medical Devices & Instruments median
No single metric tells the full story. See the SHSE:688576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chongqing Xishan Science and Technology Co Business Description
AddressNo. 9, Middle Section of Huangshan Avenue, Jupiter Science and Technology Development Center, High-tech Park, North New District, Chongqing, CHN, 401121
Chongqing Xishan Science and Technology Co Ltd focuses on surgical instruments, especially in the field of minimally invasive surgical instruments. It is mainly engaged in the research, development, production and sales of minimally invasive surgical instruments. Speculum, energy surgery equipment and other products, currently the products are mainly used in neurosurgery, ENT, orthopedics, breast surgery and other clinical departments. The company's main products are surgical power units, consumables and accessories, which are mainly used for cutting, grinding, planing, sawing, milling and trimming of bone tissue and soft tissue in surgical operations, especially minimally invasive surgical operations.
85GF Score
Get the complete analysis for SHSE:688576
ROIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688576 has been successfully added to your 
